Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases.
Fragoulis GE, Nikiphorou E, Dey M, Zhao SS, Courvoisier DS, Arnaud L, Atzeni F, Behrens GM, Bijlsma JW, Böhm P, Constantinou CA, Garcia-Diaz S, Kapetanovic MC, Lauper K, Luís M, Morel J, Nagy G, Polverino E, van Rompay J, Sebastiani M, Strangfeld A, de Thurah A, Galloway J, Hyrich KL. Fragoulis GE, et al. Among authors: behrens gm. Ann Rheum Dis. 2023 Jun;82(6):742-753. doi: 10.1136/ard-2022-223335. Epub 2022 Nov 3. Ann Rheum Dis. 2023. PMID: 36328476
Prevalence of infectious diseases, immunity to vaccine-preventable diseases and chronic medical conditions among Ukrainian refugees in Germany - A cross sectional study from the German Network University Medicine (NUM).
Brinkmann F, Friedrichs A, Behrens GM, Behrens P, Berner R, Caliebe A, Denkinger CM, Giesbrecht K, Gussew A, Hoffmann AT, Hojenski L, Hovardovska O, Dopfer-Jablonka A, Kaasch AJ, Kobbe R, Kraus M, Lindner A, Maier C, Mitrov L, Nauck M, de Miranda SN, Scherer M, Schmiedel Y, Stahl D, Timmesfeld N, Toepfner N, Vehreschild J, Wohlgemuth WA, Petersmann A, Vehreschild MJGT; NU(M)KRAINE Study Group. Brinkmann F, et al. Among authors: behrens gm. J Infect Public Health. 2024 Apr;17(4):642-649. doi: 10.1016/j.jiph.2024.02.003. Epub 2024 Feb 16. J Infect Public Health. 2024. PMID: 38458134 Free article.
Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3.
Zhang L, Kempf A, Nehlmeier I, Cossmann A, Dopfer-Jablonka A, Stankov MV, Schulz SR, Jäck HM, Behrens GMN, Pöhlmann S, Hoffmann M. Zhang L, et al. Among authors: behrens gmn. Lancet Infect Dis. 2023 Oct;23(10):e391-e392. doi: 10.1016/S1473-3099(23)00547-9. Epub 2023 Sep 13. Lancet Infect Dis. 2023. PMID: 37716358 No abstract available.
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients.
Becker M, Cossmann A, Lürken K, Junker D, Gruber J, Juengling J, Ramos GM, Beigel A, Wrenger E, Lonnemann G, Stankov MV, Dopfer-Jablonka A, Kaiser PD, Traenkle B, Rothbauer U, Krause G, Schneiderhan-Marra N, Strengert M, Dulovic A, Behrens GMN. Becker M, et al. Among authors: behrens gmn. Front Immunol. 2022 Oct 6;13:1004045. doi: 10.3389/fimmu.2022.1004045. eCollection 2022. Front Immunol. 2022. PMID: 36275672 Free PMC article.
Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals.
Barros-Martins J, Hammerschmidt SI, Morillas Ramos G, Cossmann A, Hetzel L, Odak I, Köhler M, Stankov MV, Ritter C, Friedrichsen M, Ravens I, Schimrock A, Ristenpart J, Janssen A, Willenzon S, Bernhardt G, Lichtinghagen R, Bošnjak B, Behrens GMN, Förster R. Barros-Martins J, et al. Front Immunol. 2023 May 5;14:1166589. doi: 10.3389/fimmu.2023.1166589. eCollection 2023. Front Immunol. 2023. PMID: 37215123 Free PMC article.
Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage.
Arora P, Cossmann A, Schulz SR, Ramos GM, Stankov MV, Jäck HM, Behrens GMN, Pöhlmann S, Hoffmann M. Arora P, et al. Among authors: behrens gmn. Lancet Infect Dis. 2023 Feb;23(2):147-148. doi: 10.1016/S1473-3099(22)00831-3. Epub 2023 Jan 5. Lancet Infect Dis. 2023. PMID: 36620969 Free PMC article. No abstract available.
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
Zhang L, Kempf A, Nehlmeier I, Cossmann A, Richter A, Bdeir N, Graichen L, Moldenhauer AS, Dopfer-Jablonka A, Stankov MV, Simon-Loriere E, Schulz SR, Jäck HM, Čičin-Šain L, Behrens GMN, Drosten C, Hoffmann M, Pöhlmann S. Zhang L, et al. Among authors: behrens gmn. Cell. 2024 Feb 1;187(3):596-608.e17. doi: 10.1016/j.cell.2023.12.025. Epub 2024 Jan 8. Cell. 2024. PMID: 38194966
141 results